Aptamer Sciences Inc (KOSDAQ:291650)

Revenue by Product

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	2014 - 2017
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	2014 - 2017
Analysis Service	876.25M							Upgrade
Synthetic Service	198.97M							Upgrade
Synthetic Service Growth	-7.52%							Upgrade
Excavation Service	6.86M							Upgrade
Excavation Service Growth	-75.54%							Upgrade
Lung Cancer Diagnosis Kit	735.00K							Upgrade

Revenue by Geography

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	2014 - 2017
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	2014 - 2017
South Korea	1.08B							Upgrade
South Korea Growth	345.26%							Upgrade